Skip to Content

Health

EU regulator recommends authorization for Johnson & Johnson vaccine

The European Union’s (EU) medicines regulator has recommended authorizing Johnson & Johnson’s single-dose Covid-19 vaccine. The decision from the European Medicines Agency (EMA) on Thursday comes amid vaccine supply shortages across the 27-member state bloc. “After a thorough evaluation, EMA’s human medicines committee concluded by consensus that the data on the vaccine were robust and

Continue Reading

Pfizer vaccine provides less protection in cancer patients after a single dose, study finds

The Pfizer/BioNTech Covid-19 vaccine provides less protection in cancer patients than healthy individuals following a single dose, a new real-world study in the UK suggests, raising questions about whether the UK’s strategy to delay second doses should apply to such patients. A second dose of the vaccine at three weeks, however, boosted their protection significantly,

Continue Reading

Racial disparities in Covid-19 case rates among young people were prevalent early in the pandemic, CDC study says

Early in the pandemic, young people from all racial and ethnic minority groups had higher Covid-19 case rates than non-Hispanic White people under the age of 25, according to a study published Wednesday by the US Centers for Disease Control and Prevention. Between January and April, case rates compared to young White people were about

Continue Reading